NewslettersIntestinal Cell NewsOwkin Enters Collaboration Agreement With MSD To Develop AI-Powered Diagnostics for CancerBy lbeveridge - January 5, 2024075Owkin announced that it has entered into a collaboration agreement with MSD, the tradename of Merck & Co Inc., Rahway NJ USA to develop and commercialize AI-powered digital pathology diagnostics for the European Union market.[Owkin]Press Release